Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder

Summary

This study is a community-informed, pragmatic, open-label, phase 1 clinical trial of group-format psilocybin-assisted therapy (GPAT) for individuals with post-traumatic stress disorder (PTSD). The primary objectives of this phase 1 study are to assess the safety and feasibility of (GPAT) for individuals with (PTSD) and to evaluate preliminary effects on PTSD severity.

Timeline

Start

2026-05-01

Primary completion

2027-05-01

Completion

2028-05-01

Publications

• Leeman L, Armstrong M, Menashi D, Nayo-Washington H, Marseille E, Herrera J, Romero C, Page-Reeves J. Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico. Front Public Health. 2026 Jun 17;14:1845943. doi: 10.3389/fpubh.2026.1845943. eCollection 2026.

Drugs

Indications